Gain Therapeutics GANX
NASDAQ GANX
$1.11 +0.03 (+2.78%)
At close: Nov 11, 2026 · 4:00 PM EST

Gain Therapeutics (GANX) Preferred Shares (2020)

Updated

Gain Therapeutics' Preferred Shares came in at $415.00 for Q4 2020.

Analysis

Gain Therapeutics (GANX) Preferred Shares (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Gain Therapeutics 47.87 Mn -14.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 415.00
API Access

Gain Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=GANX&period=max&api_key=YOUR_API_KEY